Skip to main content
OpenTrials

Clinical trial condition

Acute Gout

Explore clinical trials studying Acute Gout. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Acute Gout trial results

Completed

Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension Study

NCT01029652

Conditions
Acute Gout, Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Novartis Investigative Site Darlinghurst, New South Wales, Australia
  • Novartis Investigative Site Fitzroy, Victoria, Australia
  • Novartis Investigative Site Heidelberg, Victoria, Australia
  • Novartis Investigative Site Daw Park SA, Australia
View all 47 locations
View Trial Details
Completed

Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study.

NCT01080131

Conditions
Acute Gout, Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Pinnacle Research Group, LLC Anniston, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Novartis Investigative site Foley, Alabama, United States
  • Horizon Research Group, Inc. Mobile, Alabama, United States
View all 108 locations
View Trial Details
Completed

Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients

NCT00798369

Conditions
Acute Gout, Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Pinnacle Research Group, LLC Anniston, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Associated Pharmaceutical Research Buena Park, California, United States
  • Northern California Institute for Bone Health Oakland, California, United States
View all 75 locations
View Trial Details

Related conditions